Why Antares Pharma's Stock Is Trading Higher Today
Why Antares Pharma's Stock Is Trading Higher Today
Antares Pharma (NASDAQ:ATRS) shares are trading higher on Monday after the company announced a deal with Lunatus Global to distribute and promote XYOSTED in Saudi Arabia.
安塔列斯製藥(Antares Pharma)(納斯達克：ATRS)股價週一走高，此前該公司宣佈與Lunatus Global達成協議，在沙特阿拉伯分銷和推廣XYOSTED。
Antares Pharma is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others.
Antares Pharma是一家專業製藥公司。它專注於自行給藥的非腸外藥物產品和技術的開發和商業化。該公司的產品包括OTREXUP、Elestrin、Gelnique、Makena等。
Antares Pharma shares were trading up 8.81% to $2.84 at time of publication on Monday. The stock has a 52-week high of $5.13 and a 52-week low of $1.60.
週一公佈時，Antares Pharma的股價上漲8.81%，至2.84美元。該股52周高點為5.13美元，52周低點為1.60美元。
譯文內容由第三人軟體翻譯。
